INTU
57
3
HPE
38
2
MDLZ
36
6
NWSA
75
8
BEN
40
3
HBAN
47
3
GE
64
4
SO
51
3
CNX
71
3
C
54
4
CAH
47
2
MTB
40
2
ECL
57
3
LB
30
11
DHI
29
2
YUM
43
3
MCD
57
5
HP
38
4
WFC
60
2
PSX
27
2
INTU
57
3
HPE
38
2
MDLZ
36
6
NWSA
75
8
BEN
40
3
HBAN
47
3
GE
64
4
SO
51
3
CNX
71
3
C
54
4
CAH
47
2
MTB
40
2
ECL
57
3
LB
30
11
DHI
29
2
YUM
43
3
MCD
57
5
HP
38
4
WFC
60
2
PSX
27
2
Financhill
Back

Madrigal Pharmaceuticals 10K Form

Buy
51

MDGL
Madrigal Pharmaceuticals

Last Price:
$311.81
Seasonality Move:
-6.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDGL News And Ratings

See the #1 stock for the next 7 days that we like better than MDGL

MDGL Financial Statistics

Sales & Book Value

Annual Sales: $147K
Cash Flow: $-67.8M
Price / Cash Flow: 0
Annual Sales: $35.64
Price / Book: 8.76

Profitability

EPS (TTM): -25.12000
Net Income (TTM): $-518.7M
Gross Margin: $0
Return on Equity: -89.04%
Return on Assets: -62.74%

Madrigal Pharmaceuticals Earnings Forecast

Key Madrigal Pharmaceuticals Financial Ratios

  • The Selling, General & Administrative Expenses for MDGL have been equal to 7,942.86% of Gross Profit Margin.
  • The Interest Expense is -3.40% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 8 years.

Madrigal Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MDGL
CUSIP: 558868
Website: madrigalpharma.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 5.98
Quick Ratio: 5.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MDGL Technical Analysis vs Fundamental Analysis

Buy
51
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy or a Sell?